Advertisement

Cellular Cancer Markers

  • Carleton T. Garrett
  • Stewart Sell

Part of the Contemporary Biomedicine book series (CB, volume 12)

Table of contents

  1. Front Matter
    Pages i-xi
  2. Geoffrey J. Clark, Channing J. Der
    Pages 17-52
  3. Jeffrey R. Marks, Andrew M. Davidoff, J. Dirk Iglehart
    Pages 77-110
  4. Hironobu Sasano, Kiyoshi Ito, Carleton T. Garrett
    Pages 111-138
  5. Suhail Nasim, Carleton T. Garrett
    Pages 139-189
  6. Daniel S. Liscia, Tiziana Venesio, Amelia Bernardi, Alberto P. M. Cappa, Robert Callahan
    Pages 191-208
  7. Stephen J. Lemon, Anita L. Sabichi, Michael J. Birrer
    Pages 209-229
  8. Vicki Huff
    Pages 231-255
  9. H.-J. Schuurman, S. C. Henzen-Logmans, Ph. M. Kluin
    Pages 257-288
  10. Su-Ming Hsu, Pei-Ling Hsu
    Pages 289-334
  11. Paul B. Googe, Martin C. Mihm Jr.
    Pages 335-350
  12. William T. Bellamy, Thomas M. Grogan, Ronald S. Weinstein
    Pages 375-391
  13. S. V. S. Kashmiri, Patricia Horan Hand
    Pages 393-432
  14. Carleton T. Garrett, Stewart Sell
    Pages 455-477
  15. Back Matter
    Pages 479-484

About this book

Introduction

In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers reviewed have been chosen because they are biologically relevant to the growth of cells and possess an accurate and reproducible assay for detection. They also are predictors of tumor behavior, are useful in making clinical decisions, and are cost effective.

Cellular Cancer Markers provides a status report for markers of tumor cell activation, proliferation, and longevity that makes possible an informed judgment regarding the value of many newly proposed tumor markers. It also offers insight into the latest approaches to diagnosing cancer and an appreciation of how these marker-based tests can clarify the prognosis of cancer.

Keywords

antibody cancer cell leukemia lymphoma melanoma protein proteins tumor

Editors and affiliations

  • Carleton T. Garrett
    • 1
  • Stewart Sell
    • 2
  1. 1.Department of PathologyMedical College of VirginiaRichmondUSA
  2. 2.Department of Pathology and Laboratory MedicineUniversity of Texas Medical SchoolHoustonUSA

Bibliographic information

Industry Sectors
Pharma
Health & Hospitals
Biotechnology
Consumer Packaged Goods